Recent Progress of Src SH2 and SH3 Inhibitors as Anticancer Agents

By  

Current Medicinal Chemistry, Vol. 17, Iss. 12, 2010-04 ,pp. : 1117-1124

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Development of Inhibitors of SH2 Domains

By  

Current Pharmaceutical Design, Vol. 6, Iss. 1, 2000-01 ,pp. : 59-98

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based Design of Compounds Inhibiting Grb2-SH2 Mediated Protein-protein Interactions in Signal Transduction Pathways

By  

Current Pharmaceutical Design, Vol. 6, Iss. 18, 2000-12 ,pp. : 1777-1796

Bentham Science Publishers

Access to resources Recommend Favorite

New JAK2 inhibitors for myeloproliferative neoplasms

By Quintáás-Cardama Alfonso   Verstovsek Srdan  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 7, 2011-07 ,pp. : 961-972

Informa Healthcare

Access to resources Recommend Favorite

2(3)-Aryl-thio(oxy)-methylquinoxaline Derivatives: A New Class of P-Glycoprotein-Mediated Drug Efflux Inhibitors

By  

Medicinal Chemistry, Vol. 4, Iss. 3, 2008-05 ,pp. : 194-205

Bentham Science Publishers

Access to resources Recommend Favorite